Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|April 1, 1988
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivativesC R Clark, P R Halfpenny, R G Hill, et al.European Journal of Pharmacology|November 14, 1995
Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonistsL Singh, M J Field, D R Hill, et al.Journal of Medicinal Chemistry|April 17, 1992
Amide bond replacements incorporated into CCK-B selective "dipeptoids"C I Fincham, M Higginbottom, D R Hill, et al.Bioorganic & Medicinal Chemistry|February 1, 1994
Rational design of high affinity tachykinin NK2 receptor antagonistsS Boyle, S Guard, J Hodgson, et al.Bioorganic & Medicinal Chemistry|May 1, 1994
Rational design of high affinity tachykinin NK1 receptor antagonistsS Boyle, S Guard, M Higginbottom, et al.Journal of Medicinal Chemistry|June 29, 2001
Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK(1) receptor antagonistV A Ashwood, M J Field, D C Horwell, et al.Journal of Medicinal Chemistry|March 5, 1993
Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonistsP R Boden, M Higginbottom, D R Hill, et al.Molecular Pharmacology|April 1, 1993
[3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosaJ C Hunter, N Suman-Chauhan, K G Meecham, et al.Bioorganic & Medicinal Chemistry|October 1, 1996
Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988C E Augelli-Szafran, D C Horwell, C Kneen, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonistV Ashwood, V Brownhill, M Higginbottom, et al.Pageof 5